Gilgamesh Pharmaceuticals


Gilgamesh is a pioneering early-stage biotech developing novel compounds that build upon the benefits of classic psychedelics with improvements of other components such as safety, tolerability, duration, and efficacy.

Industries

Employees

11-50

Links


Org chart

Jonathan Sporn
CEO & Co-Founder
Collapse
Dalibor Sames
Co-founder
Andrew Kruegel
Chief Scientific Officer
Jeff Witkin
Preclinical Pharmacologist & Co-Founder
Robert Berman
Consultant
Yoni Falkson
Chief Operating Officer